As of 2025-07-10, the EV/EBITDA ratio of Mithra Pharmaceuticals SA (MITRA.BR) is -2.22. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MITRA.BR's latest enterprise value is 211.34 mil EUR. MITRA.BR's TTM EBITDA according to its financial statements is -95.39 mil EUR. Dividing these 2 quantities gives us the above MITRA.BR EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 4.2x - 10.7x | 5.6x |
| Forward P/E multiples | 4.7x - 14.4x | 5.9x |
| Fair Price | (9.64) - (18.20) | (11.14) |
| Upside | -4564.4% - -8524.6% | -5257.4% |
| Date | EV/EBITDA |